Sofosbuvir (Sovaldi) | Basicmedical Key
Ribavirin - Wikipedia
Ribavirin: How Does it Work and is it Still Needed? | SpringerLink
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action - ScienceDirect
Solved What is the mechanism of action of Harvoni | Chegg.com
The multifaceted functions of ribavirin: Antiviral, immunomodulator, or both? - Mondelli - 2014 - Hepatology - Wiley Online Library
Sofosbuvir (Sovaldi®)
Sofosbuvir and daclatasvir - Hessel - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library
Sofosbuvir - Wikipedia
References in Ribavirin ante portas: Uptake transporters into hepatocytes dissected - Journal of Hepatology
A review of the current anti-HCV therapy: Are we finally ready for interferon-free regimens Anantharamu T, Sharma S, Sharma AK, Gupta AK, Dahiya N, Brashier D B - Int J Nutr Pharmacol
Sofosbuvir/velpatasvir: A promising combination
References in Hepatitis C virus infection and kidney transplantation: newer options and a brighter future ahead? - Kidney International
Viruses | Free Full-Text | Hepatitis C Virus and Natural Compounds: A New Antiviral Approach? | HTML
Mode of action of ribavirin. (A) Several antiviral mechanisms for... | Download Scientific Diagram
Ribavirin: pharmacology, multiple modes of action and possible future perspectives | Future Virology
Figure1.15: Mechanisms of action of Ribavirin (136) .Proposed... | Download Scientific Diagram
Sofosbuvir, a Significant Paradigm Change in HCV Treatment
Finally sofosbuvir: an oral anti-HCV drug with wide performance capabi | PGPM
Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus | Antimicrobial Agents and Chemotherapy
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action - ScienceDirect
Mechanism of action of ribavirin in the treatment of chronic hepatitis C. - Abstract - Europe PMC
Sofosbuvir, a Significant Paradigm Change in HCV Treatment
The Discovery of Sofosbuvir: A Liver-Targeted Nucleotide Prodrug for the Treatment and Cure of HCV | SpringerLink
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir | Scientific Reports
